Oncology Central

Personalized medicine in neuro-oncology

0

The latest catch phrase in cancer medicine is ‘personalized medicine’ denoting the potential to devise and prescribe therapies based on molecular and genetic information quasi-unique to the patient and the patient’s tumor as well as therapies developed using cell line or rodent tumor model screens of drug candidates [1–8]. The molecular–genetic approach has the potential of being far more informative than the high-throughput cell line and/or rodent tumor model approach for a number of reasons.

To view restricted content, please:
Share:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.